1-3 of 3
Michael A. Grosso
Close
Sort by
Journal Articles

Impact of Thrombocytopenia on Bleeding and Recurrent Thrombosis in Cancer Associated Thrombosis: A Post Hoc Analysis of Hokusai VTE Cancer Study

Rushad Patell, Minggao Shi, Michael A. Grosso, Anil Duggal, Harry Büller, Gary E. Raskob, Jeffrey I. Zwicker
Journal: Blood
Blood (2022) 140 (Supplement 1): 5675–5676.
https://doi.org/10.1182/blood-2022-163507
Published: 2022
Journal Articles

Recurrent Venous Thromboembolism during Anticoagulation: An Investigator-Initiated Post-Hoc Analysis of the Hokusai-VTE Trial

Sabine Eichinger, MD, Min Lin, PhD, Paul A. Kyrle, MD, Michael A. Grosso, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2539.
https://doi.org/10.1182/blood-2018-99-118093
Published: 2018
Journal Articles

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Gary E. Raskob, PhD, Nick Van Es, MD, Peter Verhamme, MD PhD, Marc Carrier, MD, Marcello Di Nisio, MD, David A. Garcia, MD, Michael A. Grosso, MD, Ajay K. Kakkar, MBBS, Michael J. Kovacs, MD, Michele F. Mercuri, MD PhD FAHA, Guy Meyer, MD, Annelise Segers, MD, Minggao Shi, PhD, Tzu-Fei Wang, MD, Erik Yeo, MD FACP, FRCPC, George Zhang, PhD, Jeffrey I. Zwicker, MD, Jeffrey I. Weitz, MD, Harry R. Büller, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): LBA-6.
https://doi.org/10.1182/blood.V130.Suppl_1.LBA-6.LBA-6
Published: 2017